| 000 | 01887 a2200577 4500 | ||
|---|---|---|---|
| 005 | 20250517095247.0 | ||
| 264 | 0 | _c20171024 | |
| 008 | 201710s 0 0 eng d | ||
| 022 | _a1935-5548 | ||
| 024 | 7 |
_a10.2337/dc15-1136 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aKuhadiya, Nitesh D | |
| 245 | 0 | 0 |
_aAddition of Liraglutide to Insulin in Patients With Type 1 Diabetes: A Randomized Placebo-Controlled Clinical Trial of 12 Weeks. _h[electronic resource] |
| 260 |
_bDiabetes care _cJun 2016 |
||
| 300 |
_a1027-35 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial, Phase IV; Journal Article; Randomized Controlled Trial | ||
| 650 | 0 | 4 | _aAdult |
| 650 | 0 | 4 |
_aBlood Glucose _xmetabolism |
| 650 | 0 | 4 | _aBody Weight |
| 650 | 0 | 4 |
_aDiabetes Mellitus, Type 1 _xcomplications |
| 650 | 0 | 4 | _aDouble-Blind Method |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 |
_aGlucagon _xmetabolism |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aHypoglycemia _xchemically induced |
| 650 | 0 | 4 |
_aHypoglycemic Agents _xtherapeutic use |
| 650 | 0 | 4 |
_aInsulin _xtherapeutic use |
| 650 | 0 | 4 |
_aLiraglutide _xtherapeutic use |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMiddle Aged |
| 650 | 0 | 4 |
_aObesity _xcomplications |
| 650 | 0 | 4 |
_aOverweight _xcomplications |
| 650 | 0 | 4 | _aPostprandial Period |
| 650 | 0 | 4 | _aTime Factors |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aDhindsa, Sandeep | |
| 700 | 1 | _aGhanim, Husam | |
| 700 | 1 | _aMehta, Aditya | |
| 700 | 1 | _aMakdissi, Antoine | |
| 700 | 1 | _aBatra, Manav | |
| 700 | 1 | _aSandhu, Sartaj | |
| 700 | 1 | _aHejna, Jeanne | |
| 700 | 1 | _aGreen, Kelly | |
| 700 | 1 | _aBellini, Natalie | |
| 700 | 1 | _aYang, Min | |
| 700 | 1 | _aChaudhuri, Ajay | |
| 700 | 1 | _aDandona, Paresh | |
| 773 | 0 |
_tDiabetes care _gvol. 39 _gno. 6 _gp. 1027-35 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.2337/dc15-1136 _zAvailable from publisher's website |
| 999 |
_c26044878 _d26044878 |
||